Cargando…
Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April–June 2022
After the rapid spread of SARS-CoV-2 BA.5 Omicron lineage in Portugal, we developed a seroepidemiologic survey based on a sample of 3,825 residents. Results indicated that from April 27 through June 8, 2022, the estimated seroprevalence of SARS-CoV-2 nucleocapsid or spike IgG was 95.8%, which indica...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973687/ https://www.ncbi.nlm.nih.gov/pubmed/36732078 http://dx.doi.org/10.3201/eid2903.221546 |
| _version_ | 1784898583121625088 |
|---|---|
| author | Kislaya, Irina Melo, Aryse Barreto, Marta Henriques, Camila Aniceto, Carlos Manita, Carla Ramalhete, Sara Santos, João Almeida Soeiro, Sofia Rodrigues, Ana Paula |
| author_facet | Kislaya, Irina Melo, Aryse Barreto, Marta Henriques, Camila Aniceto, Carlos Manita, Carla Ramalhete, Sara Santos, João Almeida Soeiro, Sofia Rodrigues, Ana Paula |
| author_sort | Kislaya, Irina |
| collection | PubMed |
| description | After the rapid spread of SARS-CoV-2 BA.5 Omicron lineage in Portugal, we developed a seroepidemiologic survey based on a sample of 3,825 residents. Results indicated that from April 27 through June 8, 2022, the estimated seroprevalence of SARS-CoV-2 nucleocapsid or spike IgG was 95.8%, which indicates a high level of protection. |
| format | Online Article Text |
| id | pubmed-9973687 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Centers for Disease Control and Prevention |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99736872023-03-01 Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April–June 2022 Kislaya, Irina Melo, Aryse Barreto, Marta Henriques, Camila Aniceto, Carlos Manita, Carla Ramalhete, Sara Santos, João Almeida Soeiro, Sofia Rodrigues, Ana Paula Emerg Infect Dis Dispatch After the rapid spread of SARS-CoV-2 BA.5 Omicron lineage in Portugal, we developed a seroepidemiologic survey based on a sample of 3,825 residents. Results indicated that from April 27 through June 8, 2022, the estimated seroprevalence of SARS-CoV-2 nucleocapsid or spike IgG was 95.8%, which indicates a high level of protection. Centers for Disease Control and Prevention 2023-03 /pmc/articles/PMC9973687/ /pubmed/36732078 http://dx.doi.org/10.3201/eid2903.221546 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
| spellingShingle | Dispatch Kislaya, Irina Melo, Aryse Barreto, Marta Henriques, Camila Aniceto, Carlos Manita, Carla Ramalhete, Sara Santos, João Almeida Soeiro, Sofia Rodrigues, Ana Paula Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April–June 2022 |
| title | Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April–June 2022 |
| title_full | Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April–June 2022 |
| title_fullStr | Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April–June 2022 |
| title_full_unstemmed | Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April–June 2022 |
| title_short | Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April–June 2022 |
| title_sort | seroprevalence of specific sars-cov-2 antibodies during omicron ba.5 wave, portugal, april–june 2022 |
| topic | Dispatch |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973687/ https://www.ncbi.nlm.nih.gov/pubmed/36732078 http://dx.doi.org/10.3201/eid2903.221546 |
| work_keys_str_mv | AT kislayairina seroprevalenceofspecificsarscov2antibodiesduringomicronba5waveportugalapriljune2022 AT meloaryse seroprevalenceofspecificsarscov2antibodiesduringomicronba5waveportugalapriljune2022 AT barretomarta seroprevalenceofspecificsarscov2antibodiesduringomicronba5waveportugalapriljune2022 AT henriquescamila seroprevalenceofspecificsarscov2antibodiesduringomicronba5waveportugalapriljune2022 AT anicetocarlos seroprevalenceofspecificsarscov2antibodiesduringomicronba5waveportugalapriljune2022 AT manitacarla seroprevalenceofspecificsarscov2antibodiesduringomicronba5waveportugalapriljune2022 AT ramalhetesara seroprevalenceofspecificsarscov2antibodiesduringomicronba5waveportugalapriljune2022 AT santosjoaoalmeida seroprevalenceofspecificsarscov2antibodiesduringomicronba5waveportugalapriljune2022 AT soeirosofia seroprevalenceofspecificsarscov2antibodiesduringomicronba5waveportugalapriljune2022 AT rodriguesanapaula seroprevalenceofspecificsarscov2antibodiesduringomicronba5waveportugalapriljune2022 AT seroprevalenceofspecificsarscov2antibodiesduringomicronba5waveportugalapriljune2022 |